LTTL vs bmiMD: Costs, meds, and clinician access compared
LTTL vs bmiMD is a direct comparison of two clinician-reviewed online weight-management options. Early verdict: choose LTTL if you prioritize compounded full-dose GLP-1 prepared by U.S.A. licensed pharmacies and an advertised up to $140 off your first month; choose bmiMD if you prefer compounded tirzepatide with multiple billing options and free shipping, with monthly plans ranging from $139 to $179.
LTTL vs bmiMD: key differences at a glance
This comparison focuses on five supported differences: medication type and dosing, pricing and billing options, pharmacy verification and testing, shipping and subscriptions, and regulatory and eligibility notes. Both providers state treatment is available only when a licensed clinician determines it is medically appropriate and both note that compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
Medication type and dosing
LTTL advertises compounded full-dose GLP-1 weight loss medication. bmiMD advertises compounded GLP-1/GIP tirzepatide. This is a direct product distinction: LTTL emphasizes full-dose GLP-1 formulations, while bmiMD specifically lists tirzepatide as the compounded GLP-1/GIP option.
Pricing and billing options
LTTL lists pricing phrases including same price every dose and references prices such as $249 and $129 and up to $140 off your first month with a code auto-applied. bmiMD lists explicit monthly tiers: $179 month-to-month, $159 per month for a three-month plan, $149 per month for a six-month plan, and $139 per month for a 12-month plan, and notes the lowest price requires a longer commitment.
Pharmacy verification, testing, and delivery
Both providers state medications are prepared in state-licensed pharmacies and delivered to your door. LTTL states medications are compounded by U.S.A. licensed pharmacies and prepared in a state-licensed pharmacy, independently verified in FDA registered labs, and confirmed every 3–6 months to stay within ± 10% of target strength. bmiMD states medications are prepared in a state-licensed pharmacy, independently verified in FDA- and DEA-registered labs, and also confirmed every 3–6 months to stay within ± 10% of target strength.
Confirm LTTL pharmacy verifications
Shipping, subscriptions, and clinician access
bmiMD highlights free shipping on every subscription order, four billing options, online refills and delivery, and 24/7 clinician access in captured landing-page evidence. LTTL highlights delivery to your door when you need it and mentions the first-month promotional language up to $140 off with code auto-applied; captured evidence does not list free shipping or 24/7 clinician access for LTTL.
Browse bmiMD subscription options
LTTL vs bmiMD comparison table
| Criteria | LTTL | bmiMD |
|---|---|---|
| Primary medication | Compounded full-dose GLP-1 | Compounded GLP-1/GIP (tirzepatide) |
| Starting price / plans | Mentions same price every dose; references $249, $129; up to $140 off your first month | $179 mo (1 mo); $159 mo (3 mo); $149 mo (6 mo); $139 mo (12 mo) |
| Pharmacy & lab verification | Compounded by U.S.A. licensed pharmacies; verified in FDA registered labs; strength confirmed every 3–6 months | Prepared in state-licensed pharmacy; verified in FDA- and DEA-registered labs; strength confirmed every 3–6 months |
| Shipping & subscriptions | Delivered to your door; promotional credit up to $140 off first month noted | Free shipping on every subscription order; online refills and delivery; multiple billing options |
| Clinician review & eligibility | Treatment only when a licensed clinician determines medically appropriate; eligibility and state availability may vary | Treatment only when a licensed clinician determines medically appropriate; eligibility and state availability may vary |
Regulatory and eligibility notes
Both LTTL and bmiMD explicitly note that compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Both list that treatment is available only when a licensed clinician determines it is medically appropriate. LTTL also cautions that pricing, eligibility, pharmacy, state coverage and renewal terms may change; bmiMD notes the lowest price requires a 12-month commitment and that total prepaid charge should be confirmed.
How to decide: choose based on what matters most
Use the primary keyword when comparing options: LTTL vs bmiMD. If you want a provider that advertises compounded full-dose GLP-1 prepared by U.S.A. licensed pharmacies and promotes up to $140 off your first month, LTTL presents those claims. If you want tirzepatide and explicit multi-month pricing tiers with free subscription shipping and 24/7 clinician access in the captured evidence, bmiMD presents those claims.
Choose based on the evidence
Choose LTTL if you prioritize compounded full-dose GLP-1 prepared by U.S.A. licensed pharmacies and the advertised up to $140 off your first month. Choose bmiMD if you prefer compounded tirzepatide, multiple billing lengths with a lower long-term monthly equivalent, and free subscription shipping. Confirm eligibility, medication, total cost, renewal terms and state availability with either provider before enrollment.